Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials

Journal of Clinical Oncology - United States
doi 10.1200/jco.2015.66.2346
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Concomitant Medications and Risk of Chemotherapy‐Induced Peripheral Neuropathy

Oncologist
Cancer ResearchMedicineOncology
2018English

Chemotherapy-Induced Peripheral Neuropathy

JAMA Oncology
Cancer ResearchOncology
2019English

In Search of a Gold Standard Patient-Reported Outcome Measure for Use in Chemotherapy- Induced Peripheral Neuropathy Clinical Trials

Cancer Control
MedicineOncologyHematology
2018English

The Relationship Between Oncology Nurses’ Practice Behaviors, Knowledge and Confidence Regarding Chemotherapy Induced Peripheral Neuropathy

Port Said Scientific Journal of Nursing
2017English

Dietary Intake of Magnesium or Calcium and Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer Patients

Nutrients
NutritionFood ScienceDietetics
2018English

Nutraceuticals for Prevention of Chemotherapy-Induced Peripheral Neuropathy

Nutraceuticals and Innovative Food Products for Healthy Living and Preventive Care
English

Role of Erythropoeitin in Prevention of Chemotherapy-Induced Peripheral Neuropathy

Pakistan Journal of Biological Sciences
AgronomyCrop Science
2010English

Comparing Outcomes of Concurrent Chemotherapy Regimens in Patients 65 Years or Older With Locally Advanced Oropharyngeal Carcinoma

Cancer
Cancer ResearchOncology
2018English

Acupuncture and Reflexology for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer

Integrative Cancer Therapies
OncologyAlternative MedicineComplementary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy